The effects of iontophoresis and electroporation on transdermal delivery of buprenorphine from solutions and hydrogels.
The in-vitro permeation of buprenorphine across skin was investigated to assess the effects of iontophoresis and electroporation on drug permeation from solutions as well as from hydrogels. Iontophoresis (0.3 mA cm(-2)) increased the buprenorphine permeation from solution by a factor of 14.27 as compared with passive diffusion; the application of electroporation increased the buprenorphine permeation from solutions by a factor of 8.45. The permeation experiments using cellulose membrane and stratum corneum (SC)-stripped skin as permeation barriers suggested that the enhancement with iontophoresis was primarily due to strong electrophoretic drift of buprenorphine molecules, whereas the enhancement seen with electroporation was mainly attributed to the creation of transient aqueous pores in the SC layer. Application of high-voltage pulses followed by iontophoresis resulted in a shorter permeation onset time from both solutions and hydrogels as compared with iontophoresis or electroporation alone. The charge repulsion between buprenorphine and chitosan vehicles as well as the competition effects of counter-ions for carboxymethylcellulose (CMC)-based polymers may account for the different permeation rates under electrical field. This study demonstrates the feasibility of using hydrogels for delivery of buprenorphine under the application of iontophoresis or electroporation, separately or together.
Fang
Jia-You
JY
Pharmaceutics Laboratory, Graduate Institute of Natural Products, Chang Gung University, Kwei-Shan, Tao-Yuan, Taiwan. fajy@mail.cgu.edu.tw
Sung
K C
KC
Wang
Jhi-Joung
JJ
Chu
Chin-Chen
CC
Chen
Kuan-Ting
KT
D000279:Administration, Cutaneous; D000818:Animals; D002047:Buprenorphine / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D002851:Chromatography, High Pressure Liquid; D018274:Electroporation; D005260:Female; D020100:Hydrogels; D007478:Iontophoresis; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D009292:Narcotic Antagonists / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D012869:Skin Absorption; D012996:Solutions; D014783:Viscosity
D020100:Hydrogels; D009292:Narcotic Antagonists; D012996:Solutions; D002047:Buprenorphine